Abatacept, currently used to treat RA symptoms, was prescribed weekly for 12 months to 110 participants with early RA symptoms such as joint pain. Compared with the control group, rates of progression to full-blown RA were significantly reduced; Only 27 participants showed improvement at two years, compared to 38 in the placebo group.
Principal investigator Professor Andrew Cope, of King’s College London, expressed optimism about the findings: “This is the first time that established RA treatment has been effective in preventing its onset. “This gives hope to people at risk and could greatly reduce the physical and economic burden of this disease. ”
News materials cannot be equated with a doctor’s prescription. Consult an expert before making a decision.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
